22147-Gall Bladder Cancer-NA-1263

Gall Bladder Cancer

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: NA
USOR Number:

  • Address

18707 Hardy Oak Blvd.
San Antonio, TX 78258
P: (210) 545-6972

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 1,400 physicians and over 500 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.